Teva Pharma wins 1st round of patent battle against Natco

New Delhi: In a setback to Hyderabad-based Natco Pharma, the Israeli drug giant Teva Pharma claims to have won the first round of patent battle over the blockbuster multiple sclerosis drug Copaxone (Glatiramer Aceatte) in the United States. Teva Pharma said on Monday that the US District Court for the Southern District of New York has issued a favourable set of claim construction rulings in the company’s patent infringement lawsuit against Natco...